Application of combined intraperitoneal and intravenous neoadjuvant chemotherapy in senile patients with advanced ovarian cancer and massive ascites.

E L LiuR R MiD H WangL Q WangY M ZhangW M Chen

Published in: European journal of gynaecological oncology (2018)

Neoadjuvant chemotherapy can obviously shorten the operation duration, reduce the intraoperative blood loss, and improve the ideal success rate of cytoreductive surgery, but does not obviously improve the prognosis.

Keyphrases

neoadjuvant chemotherapy
locally advanced
lymph node
sentinel lymph node
minimally invasive
coronary artery bypass
high dose
rectal cancer
patients undergoing
squamous cell carcinoma
radiation therapy
coronary artery disease
low dose
percutaneous coronary intervention
atrial fibrillation
surgical site infection